Drug Shortage Report for JAMP-IRBESARTAN AND HYDROCHLOROTHIAZIDE

Last updated on 2017-08-08 History
Report ID 4434
Drug Identification Number 02418258
Brand name JAMP-IRBESARTAN AND HYDROCHLOROTHIAZIDE
Common or Proper name Irbesartan Hydrochlorothiazide Tablets
Company Name JAMP PHARMA CORPORATION
Market Status CANCELLED POST MARKET
Active Ingredient(s) HYDROCHLOROTHIAZIDE IRBESARTAN
Strength(s) 25MG 300MG
Dosage form(s) TABLET
Route of administration ORAL
Packaging size 28
ATC code C09DA
ATC description ANGIOTENSIN II ANTAGONISTS, COMBINATIONS
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2016-09-15
Estimated end date 2017-08-31
Actual end date 2017-04-28
Shortage status Resolved
Updated date 2017-08-08
Company comments
Health Canada comments
Tier 3 Status No
Contact Address 1310 RUE NOBEL
BOUCHERVILLE, QUEBEC
CANADA J4B 5H3
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v7 2017-08-08 French Compare
v6 2017-08-08 English Compare
v5 2017-07-12 French Compare
v4 2017-07-12 English Compare
v3 2017-04-29 English Compare
v2 2017-03-27 French Compare
v1 2017-03-27 English Compare

Showing 1 to 7 of 7